FREDERICK, Md., June 7 /PRNewswire-FirstCall/ -- BioElectronics Corporation, , announced today that Grup H.E.R. Saglik Sistemleri SAN a distributor for healthcare products in Turkey has signed an agreement to introduce ActiPatch, the unique drug free therapy for treatment of swelling, pain, and soft and hard tissues injuries.
“We are so excited to have the opportunity of executing the sales and marketing of a highly innovative product, ActiPatch, in Turkey. Feedback from specialists on the product has been significantly positive so far; they have been impressed by its wide area of indication, user-friendly design, and provision of drug-free anti-inflammatory therapy as well as its safety, effectiveness in pain control and wound care, sustained by clinical studies. The continued professionalism of Bioelectronics Corp. along with our Company’s experience will make ActiPatch utilized by a wide range of users among Turkey,” said Demet ORAK, Project Coordinator, GRUP H.E.R. SAGLIK SISTEMLERI,TURKEY
“We welcome Grup H.E.R. Saglik Sistemleri SAN as the newest member of our international distribution team. We are pleased to do business with this growing firm and expect to achieve significant penetration into the Turkish medical market through our newly established relationship,” said Andrew Whelan, President of BioElectronics Corporation.
About Grup H.E.R. Saglik Sistemleri SAN:
Founded in 2001, this young company has strived to provide the latest in medical equipment to the medical professionals in Turkey. For more information visit their website: http://www.grupher.com.tr/main.htm
About BioElectronics:
BioElectronics Corporation is the maker of ActiPatch(TM). ActiPatch is a drug-free anti-inflammatory patch with an embedded battery operated microchip that delivers weeks of continuous pulsed therapy for less than a dollar a day. The unique ActiPatch delivery system, using patented technology, provides a cost-effective, patient friendly method to reduce soft tissue pain and swelling.
For more information visit http://www.bioelectronicscorp.com
Safe Harbor Statement:
This news release contains forward-looking statements related to future growth and earnings opportunities. Such statements are based upon certain assumptions and assessments made by management of both companies in light of current conditions, expected future developments and other factors it believes to be appropriate. Actual results may differ as a result of factors over which the companies have no control.
BioElectronics Corporation
CONTACT: Andrew J. Whelan, President & CEO, BioElectronics,+1-866-757-2284, or fax, +1-301-874-6935, or info@actipatch.net
